India to Netherlands: Herbal Export Trade Route

The India to Netherlands Herbal corridor is one of India's established pharmaceutical export routes, with 158 shipments documented worth a combined $1.3M USD. The route is dominated by DALMIA HEALTHCARE LIMITED, which alone accounts for roughly 49% of all export value, reflecting the consolidated nature of India's herbal manufacturing sector.

Across 23 active suppliers, the average shipment value stands at $8.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during January–March, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 16.0%, placing it at rank #10 among India's top herbal export destinations globally.

On the import side, key buyers of Indian herbal in Netherlands include SUN WAVE PHARMA SRL, SUN WAVE PHARMA S.R.L. , SUN WAVE PHARMA S R L and 27 others. SUN WAVE PHARMA SRL is the single largest importer with 8 shipments valued at $429.1K USD.

India's herbal exports to Netherlands are driven primarily by a handful of large-scale manufacturers. DALMIA HEALTHCARE LIMITED with 11 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 23 active exporters signals a competitive but concentrated market — buyers in Netherlands benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — DALMIA HEALTHCARE LIMITED, DALMIA HEALTHCARE LIMITED , MAHARISHI AYURVEDA PRODUCTS PRIVATE LIMITED — together account for 89% of total trade value on this route. The average shipment value of $8.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as herbalformulations astha- 15 capsule batch no. ahc-2315-r manufacturing dt. august 2023 exp dt. july 2026 and herbalformulations astha- 15 capsule batch no. ahc-2314-r manufacturing dt. august 2023 exp dt. july 2026, suggesting that buyers in Netherlands tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, SUN WAVE PHARMA SRL is the largest importer with 8 shipments worth $429.1K USD — representing 34% of all herbal imports from India on this route. A total of 30 buyers are active on this corridor.